We could speculate that the improved lipid profile in NAFLD patients carrying the rs599839 genetic variation may be explained by the enhanced LDL lysosomal degradation in hepatocytes and macrophages, due to the increased sortilin 1 expression. Here, SORT1 is linked to metabolic dysfunction-associated steatotic liver disease.